Strong Thursday previews of $3.5 million for the R-rated DC body horror film have anchored trader expectations around a $21–24 million domestic opening, with the tightest brackets reflecting solid but not breakout presales. Positive early reviews (roughly 74–75% on Rotten Tomatoes) and first-reaction buzz praising practical effects, Tom Rhys Harries’ lead turn, and gruesome transformations have supported momentum, while the $44 million budget keeps profitability thresholds modest. Competition from the expanding A24 documentary “You Can See Everything,” which is tracking for a potentially strong second weekend, adds downside risk and caps upside projections near $25 million. Traders appear to weigh the genre timing and word-of-mouth potential against mixed presale trends and a crowded adult audience landscape as the weekend unfolds.